City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

New hormone and immunotherapy trial for breast cancer patients

October 8, 2018 | City of Hope

This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.

What Is Metastatic Triple-negative Breast Cancer?

October 2, 2018 | Kevin Chesley

City of Hope's Yuan Yuan, M.D., Ph.D, knows that those faced with metastatic triple-negative breast cancer have a tough fight ahead of them, but she is working to make that battle more surmountable.

Pregnant with Cancer: One Patient’s Remarkable Journey

August 15, 2018 | Alison Shore

City of Hope's I. Benjamin Paz, M.D., recognizes the unique dilemma of cancer during pregnancy because mapping the treatment course must consider two lives.

Her breast cancer diagnosis was grim; a second opinion saved her life

July 15, 2017 | City of Hope

At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer.

‘Faces of Disparity’: A Month-long Exploration of Minority Health Issues

April 4, 2017 | Stephanie Smith

City of Hope is dedicating every day in April, National Minority Health Month, to beginning to examine important issues of disparity in health care.

New Study: Deploying Genetic Screens Early May Offer Some Benefits

February 7, 2017 | Jyoti Madhusoodanan

Next-generation sequencing (NGS) tests can quickly pinpoint tumor mutations that can be targeted with specific drugs, offering a route to precision therapies for many cancer types. Coupled with new drugs that target tumor-specific genomic changes, NGS tests carry the potential to transform modern cancer care.

Researcher receives grant to study aggressive form of breast cancer

June 22, 2016 | Michael Easterling

Victoria Seewaldt, M.D., the Ruth Ziegler professor and chair in the Department of Population Sciences at City of Hope, has received a two-year grant from the Prevent Cancer Foundation to support her research in early detection and triple-negative breast cancer, a highly aggressive form of cancer.